NCT01823640View on ClinicalTrials.gov

Experimental Human Rhinovirus Infection

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2014

Conditions
Common Cold
Interventions
OTHER

placebo

OTHER

Human Rhinovirus strain 16 (HRV-16)

100 TCID50 dosis of HRV-16 will be inoculated on day 7 and / or day 0

Trial Locations (1)

6525 HB

Radboud University Nijmegen Medical Centre, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT01823640 - Experimental Human Rhinovirus Infection | Biotech Hunter | Biotech Hunter